Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04955730 · ClinicalTrials.gov registry record · Phase 2
NPWT in Patients Undergoing Surgical Procedures for Management of GI Malignancies
A Phase 2 study of Surgical Wound Infection, sponsored by H. Lee Moffitt Cancer Center and Research Institute.
- Active
- Registry status
- Phase 2
- Development phase
- 290
- Enrollment target
- 1
- Study location
NCT04955730: Active Phase 2 study of Surgical Wound Infection, sponsored by H. Lee Moffitt Cancer Center and Research Institute.
NCT04955730 is a Phase 2 study of Surgical Wound Infection that is active but no longer recruiting, run by H. Lee Moffitt Cancer Center and Research Institute. The registered enrollment target is 290 participants, below the 892-participant average among 8 other Surgical Wound Infection trials with a reported enrollment target (67% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04955730, a Phase 2 study of Surgical Wound Infection, is active but no longer recruiting, sponsored by H. Lee Moffitt Cancer Center and Research Institute.
- ACTIVE NOT RECRUITING
- Registry status
- Phase 2
- Development phase
- 290 participants
- Enrollment target
- 1
- Study location
Study Summary
This randomized trial will use a Negative Pressure Wound Therapy device or standard wound closure, in participants with gastrointestinal neoplasms, to measure the rate of surgical site infections
Primary Outcome
Investigators will measure rate of Surgical Site Infection (SSI) of participants who received Superficial Incisions.
Conditions Studied
Interventions
- DEVICE Negative Pressure Wound Therapy
Study Locations (1)
Florida
- Moffitt Cancer Center - Tampa
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 290 participants |
| Start Date | 2021-08-05 |
| Est. Completion | 2026-03 |
| Phase | Phase 2 |
What the registry record for NCT04955730 still lists
NCT04955730 is an interventional study that assigns participants to a tested intervention. The registered 290 participants enrollment target is mid-sized for trials with a published cap, below the 892-participant average among 8 other Surgical Wound Infection trials with a reported enrollment target (67% lower).
The record links to 1 condition, with Surgical Wound Infection appearing as the primary indexed condition, and to 1 intervention - of which Negative Pressure Wound Therapy is the first listed.
NCT04955730 reports a single indexed study location in Florida.
Frequently Asked Questions
What is clinical trial NCT04955730 about?
NCT04955730 is a clinical study titled "NPWT in Patients Undergoing Surgical Procedures for Management of GI Malignancies". This randomized trial will use a Negative Pressure Wound Therapy device or standard wound closure, in participants with gastrointestinal neoplasms, to measure the rate of surgical site infections
What is the current status of trial NCT04955730?
This trial is currently active not recruiting. It is a Phase 2 study. The enrollment target is 290 participants. The study started on 2021-08-05. Estimated completion is 2026-03.
What conditions does trial NCT04955730 study?
This clinical trial studies the following conditions: Surgical Wound Infection.
What interventions are being tested in trial NCT04955730?
The interventions under investigation include: Negative Pressure Wound Therapy (DEVICE).
Who is sponsoring clinical trial NCT04955730?
This trial is sponsored by H. Lee Moffitt Cancer Center and Research Institute, which has 502 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04955730 being conducted?
This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Surgical Wound Infection
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04955730's enrollment target sits among peer trials
290 6th of 8 higher than 3 of 8 other Surgical Wound Infection trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Surgical Wound Infection trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
The Effect of Bacterial Decolonization Before Skin Cancer Surgery on Infection Rate of Lower Extremity Wounds Left Open to Heal
RECRUITING · Phase 3
-
Light-Activated Antimicrobial Therapy to Prevent Surgical Site Infections
RECRUITING · Phase 3
-
A Study of Amicidin-β Topical Solution for Patients With Surgical or Traumatic Wound Infections
RECRUITING · Phase 1
-
Reducing Intraoperative ESKAPE Transmission Through Use of a Personal Hand Hygiene System
RECRUITING · NA
-
Local Warming of Surgical Incisions
COMPLETED · Phase 3
-
Topical Antibiotic Prophylaxis for Eyelids
COMPLETED · Phase 4
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00775476 · 290 participants · Phase 2
Treatment of Systemic Lupus Erythematosus (SLE) With N-acetylcysteine
- NCT01874197 · 290 participants · NA
Branched Thoracic Endovascular Grafts for the Treatment of Thoraco-abdominal Aortic
- NCT04331353 · 290 participants · NA
The Allergen Reduction and Child Health Study (ARCHS)
- NCT04649008 · 290 participants · Early Phase 1
Localizing Epileptic Networks Using MRI and iEEG
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI